1752 logo

Nang Kuang Pharmaceutical Co., Ltd. Stock Price

TWSE:1752 Community·NT$3.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

1752 Share Price Performance

NT$0
-44.15 (-100.00%)
NT$0
-44.15 (-100.00%)
Price NT$0

1752 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Solid track record with excellent balance sheet.

1 Risk
2 Rewards

Nang Kuang Pharmaceutical Co., Ltd. Key Details

NT$2.2b

Revenue

NT$1.4b

Cost of Revenue

NT$808.2m

Gross Profit

NT$551.1m

Other Expenses

NT$257.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
2.55
36.34%
11.56%
28.3%
View Full Analysis

About 1752

Founded
1963
Employees
n/a
CEO
Yu-Bei Wang
WebsiteView website
www.nangkuang.com.tw

Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion bags. It also provides various products in the areas of cardiovascular, gastrointestinal, nervous, musculo-skeletal, and respiratory system, as well as in alimentary and metabolism, blood, antineoplastic and immunomodulatory, dermatological, genito-urinary and sex hormone, systemic hormone and antibacterial, cosmetics, and hospital solutions. In addition, the company is involved in trading of pharmaceuticals. Nang Kuang Pharmaceutical Co., Ltd. was founded in 1963 and is headquartered in Tainan City, Taiwan.

Recent 1752 News & Updates

Recent updates

No updates